Suppr超能文献

抗氧化剂N-乙酰半胱氨酸可抑制血管活性物质增强的轻度氧化低密度脂蛋白对血管平滑肌细胞的促有丝分裂作用。

Antioxidant N-acetylcysteine inhibits vasoactive agents-potentiated mitogenic effect of mildly oxidized LDL on vascular smooth muscle cells.

作者信息

Watanabe Takuya, Pakala Rajbabu, Katagiri Takashi, Benedict Claude R

机构信息

Third Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan.

出版信息

Hypertens Res. 2002 Mar;25(2):311-5. doi: 10.1291/hypres.25.311.

Abstract

Mildly oxidized LDL (mox-LDL) has been shown to induce monocyte-endothelial interactions and vascular smooth muscle cell (VSMC) proliferation, key events in the formation of the atherosclerotic lesion. Growth factors and vasoactive peptides are also thought to play a major role in atherogenesis. We examined the interaction between mox-LDL and well-known vasoactive agents such as serotonin (5-HT), angiotensin II (Ang-II), endothelin-1 (ET-1), or urotensin II (U-II) in inducing DNA synthesis in VSMCs. Growth-arrested VSMCs were incubated with different concentrations of native LDL, mox-LDL, or highly oxidized LDL (ox-LDL) with 5-HT, Ang-II, ET-1, or U-II in the absence or presence of N-acetylcysteine (NAC), an intracellular free radical scavenger. DNA synthesis in VSMCs was examined by [3H]thymidine incorporation into cellular DNA. Mox-LDL and ox-LDL stimulated [3H]thymidine incorporation with a maximal effect at 5 microg/ml (211%, 154%), which values were significantly greater than that for native LDL (128%). 5-HT, Ang-II, ET-1, or U-II also stimulated [3H]thymidine incorporation in a dose-dependent manner. 5-HT had a maximal stimulatory effect at a concentration of 50 micromol/l (205%), Ang-II at 1.75 micromol/l (202%), ET-1 at 0.1 micromol/l (205%), and U-II at 0.05 micromol/l (161%). When added together, mox-LDL (100 ng/ml)-induced [3H]thymidine incorporation was potentiated by low concentrations of 5-HT (1 micromol/l), Ang-II (0.5 micromol/l), ET-1 (1 nmol/l), or U-II (10 nmol/l) (114% to 330%, 325%, 338%, or 345%, respectively). Synergistic interactions of mox-LDL with 5-HT, Ang-II, ET-1, or U-II were significantly inhibited by NAC (400 micromol/l). Our results suggest that mild oxidation of LDL may enhance its atherogenic potential and exert a synergistic interaction with vasoactive agents in inducing DNA synthesis via the generation of reactive oxygen species in VSMCs.

摘要

轻度氧化的低密度脂蛋白(mox-LDL)已被证明可诱导单核细胞与内皮细胞相互作用以及血管平滑肌细胞(VSMC)增殖,这些是动脉粥样硬化病变形成中的关键事件。生长因子和血管活性肽也被认为在动脉粥样硬化发生过程中起主要作用。我们研究了mox-LDL与知名血管活性物质如5-羟色胺(5-HT)、血管紧张素II(Ang-II)、内皮素-1(ET-1)或尾加压素II(U-II)在诱导VSMC中DNA合成方面的相互作用。将生长停滞的VSMC与不同浓度的天然LDL、mox-LDL或高度氧化的LDL(ox-LDL)以及5-HT、Ang-II、ET-1或U-II一起孵育,同时存在或不存在细胞内自由基清除剂N-乙酰半胱氨酸(NAC)。通过将[3H]胸腺嘧啶核苷掺入细胞DNA来检测VSMC中的DNA合成。mox-LDL和ox-LDL刺激[3H]胸腺嘧啶核苷掺入,在5μg/ml时具有最大效应(分别为211%、154%),这些值显著高于天然LDL(128%)。5-HT、Ang-II、ET-1或U-II也以剂量依赖性方式刺激[3H]胸腺嘧啶核苷掺入。5-HT在浓度为50μmol/l时具有最大刺激效应(205%),Ang-II在1.75μmol/l时(202%),ET-1在0.1μmol/l时(205%),U-II在0.05μmol/l时(161%)。当一起添加时,低浓度的5-HT(1μmol/l)、Ang-II(0.5μmol/l)、ET-1(1nmol/l)或U-II(10nmol/l)可增强mox-LDL(100ng/ml)诱导的[3H]胸腺嘧啶核苷掺入(分别为114%至330%、325%、338%或345%)。NAC(400μmol/l)可显著抑制mox-LDL与5-HT、Ang-II、ET-1或U-II的协同相互作用。我们的结果表明,LDL的轻度氧化可能增强其动脉粥样硬化潜力,并通过在VSMC中产生活性氧物种与血管活性物质在诱导DNA合成方面发挥协同相互作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验